OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
Companies/Materials/WLK
WLKNYSE—63

WESTLAKE CORP

Commodity ChemicalsVerified

WESTLAKE CORP (WLK) is currently classified as Chemicals within Commodity Chemicals (Basic Materials). Classification confidence: 0.92 (verified market data). Capital structure on the latest snapshot: total assets 19,961,000,000 USD, total equity 8,792,000,000, short-term debt 497,000,000, long-term debt 5,087,000,000. Net cash position is approximately -2,860,000,000 USD. Profitability profile: revenue 11,170,000,000, gross profit 813,000,000, operating income -1,578,000,000, net income -1,508,000,000. Return on equity ~-17.2%. Return on assets ~-7.5%. Operating-cash-flow to net-income ratio is -0.31. Risk profile from automated assessment: liquidity risk medium, dilution risk unknown. Flags: Net cash is negative after subtracting total debt.; Dilution risk could not be assessed (basic + diluted share counts missing)..

30-day price · WLK-17.45 (-16.4%)
Low$88.32High$124.23Close$89.08As of15 May, 00:00 UTC
Profile
CompanyWESTLAKE CORP
ExchangeNYSE
TickerWLK
CIK0001262823
SICIndustrial Organic Chemicals
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. WESTLAKE CORP is classified under Basic Materials / Commodity Chemicals and appears not currently profitable on the latest normalized snapshot.

Classification. Classification confidence is 0.92 based on verified market data; matched terms: Commodity Chemicals, Chemicals, Basic Materials.

WESTLAKE CORP (WLK) is currently classified as Chemicals within Commodity Chemicals (Basic Materials). Classification confidence: 0.92 (verified market data). Capital structure on the latest snapshot: total assets 19,961,000,000 USD, total equity 8,792,000,000, short-term debt 497,000,000, long-term debt 5,087,000,000. Net cash position is approximately -2,860,000,000 USD. Profitability profile: revenue 11,170,000,000, gross profit 813,000,000, operating income -1,578,000,000, net income -1,508,000,000. Return on equity ~-17.2%. Return on assets ~-7.5%. Operating-cash-flow to net-income ratio is -0.31. Risk profile from automated assessment: liquidity risk medium, dilution risk unknown. Flags: Net cash is negative after subtracting total debt.; Dilution risk could not be assessed (basic + diluted share counts missing)..
Key takeaways
  • Return on equity is about -17.2%.
  • Debt to equity is about 0.64x.
Financial snapshot
PeriodFY2025
CurrencyUSD
Revenue$11.17B
Gross profit$813.0M
Operating income-$1.58B
Net income-$1.51B
R&D—
SG&A—
D&A$1.18B
SBC$41.0M
Operating cash flow$465.0M
CapEx$995.0M
Free cash flow-$530.0M
Total assets$19.96B
Total liabilities$10.67B
Total equity$8.79B
Cash & equivalents$2.72B
Long-term debt$5.09B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY2025$11.17B-$1.58B-$1.51B-$530.0M
FY2024$12.14B$875.0M$602.0M$306.0M
FY2025$12.14B$875.0M$602.0M$306.0M
FY2023$12.55B$729.0M$479.0M$1.30B
FY2024$12.55B$729.0M$479.0M$1.30B
PeriodGross %Op %Net %FCF %
FY2025————
FY2024————
FY2025————
FY2023————
FY2024————
PeriodAssetsEquityCashDebt
FY2025$19.96B$8.79B$2.72B—
FY2024$20.75B$10.53B$2.92B—
FY2025$20.75B$10.53B$2.92B—
FY2023$21.04B$10.24B$3.30B—
FY2024$21.04B$10.24B$3.30B—
PeriodOCFCapExFCFSBC
FY2025$465.0M$995.0M-$530.0M$41.0M
FY2024$1.31B$1.01B$306.0M$41.0M
FY2025$1.31B$1.01B$306.0M$41.0M
FY2023$2.34B$1.03B$1.30B$43.0M
FY2024$2.34B$1.03B$1.30B$43.0M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
Q3 2025$8.64B-$907.0M-$964.0M-$514.0M
Q2 2025$5.80B-$141.0M-$182.0M-$457.0M
Q3 2025————
Q1 2025$2.85B-$32.0M-$40.0M-$325.0M
PeriodGross %Op %Net %FCF %
Q3 2025————
Q2 2025————
Q3 2025————
Q1 2025————
PeriodAssetsEquityCashDebt
Q3 2025$19.81B$9.43B$1.93B—
Q2 2025$20.81B$10.28B$2.08B—
Q3 2025—$10.79B——
Q1 2025$20.71B$10.41B$2.30B—
PeriodOCFCapExFCFSBC
Q3 2025$240.0M$754.0M-$514.0M$30.0M
Q2 2025$58.0M$515.0M-$457.0M$19.0M
Q3 2025————
Q1 2025-$77.0M$248.0M-$325.0M$7.0M
Valuation
Market price—
Market cap—
Enterprise value—
P/E—
Reported non-GAAP P/E—
EV/Revenue—
EV/Op income—
EV/OCF—
P/B—
P/Tangible book—
Tangible book$7.24B
Net cash-$2.86B
Current ratio2.2
Debt/Equity0.6
ROA-7.5%
ROE-17.2%
Cash conversion-31.0%
CapEx/Revenue8.9%
SBC/Revenue0.4%
Asset intensity0.4
Dilution ratio—
Risk assessment
Dilution riskUnknown
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
  • Dilution risk could not be assessed (basic + diluted share counts missing).
Industry benchmarks
Activity: Chemicals · cohort 11 companies
MetricWLKActivity
Op margin-14.1%0.4% medp25 -8.0% · p75 16.0%bottom quartile
Net margin-13.5%2.3% medp25 -11.6% · p75 11.8%bottom quartile
Gross margin7.3%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue—1.1% medp25 0.5% · p75 1.3%
CapEx / revenue8.9%6.2% medp25 5.4% · p75 10.2%above median
Debt / equity64.0%59.0% medp25 54.9% · p75 72.9%above median
Observations
IR observations
market data ESG controversies score21.2
market data ESG governance pillar20.5
market data ESG social pillar27.1
market data insider trading score3.0
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
SEC filingstype companyfacts · CIK 0001262823 · 580 us-gaap concepts
data.sec.gov/CIK0001262823.json
2026-05-01 09:51 UTC#51247c0d
Source: analysis-pipeline (hybrid)Generated: 2026-05-01 09:52 UTCJob: 97c44391